MedTrace Logo

Clinical Trials

Showing trials with last updates posted in 2026.

NCT03442556 | TERMINATED | PHASE2
18 participants

Docetaxel, Carboplatin, and Rucaparib Camsylate in Treating Patients With Metastatic Castration Resistant Prostate Cancer With Homologous Recombination DNA Repair Deficiency

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-26
Start Date:
2018-08-24
Completion:
2025-06-04
Conditions
  • ATM Gene Mutation
  • BRCA1 Gene Mutation
  • BRCA2 Gene Mutation
  • Castration Levels of Testosterone
  • Castration-Resistant Prostate Carcinoma
  • Homologous Recombination Deficiency
  • Prostate Carcinoma Metastatic in the Bone
  • PSA Level Greater Than or Equal to Two
  • PSA Progression
  • Stage IV Prostate Adenocarcinoma AJCC v7
Interventions
  • DRUG
  • OTHER
Results Available
NCT03204123 | ACTIVE_NOT_RECRUITING | PHASE2
1171 participants

PSMA PET Imaging of Recurrent Prostate Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-26
Start Date:
2017-06-26
Completion:
2027-06-30
Conditions
  • Prostate Adenocarcinoma
  • Prostate Cancer
Interventions
  • DRUG
  • DIAGNOSTIC_TEST
No Results Yet
NCT03173937 | RECRUITING | PHASE1/PHASE2
37 participants

Unrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS Using CordIn(TM), Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells to Expedite Engraftment and Improve Transplant Outcome

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-26
Start Date:
2017-06-13
Completion:
2027-04-28
Conditions
  • Severe Aplastic Anemia
  • Hypo-Plastic MDS
  • Myelodysplastic Syndrome (MDS)
Interventions
  • BIOLOGICAL
  • DEVICE
No Results Yet
NCT03048084 | RECRUITING | PHASE4
120 participants

Seizure Treatment in Glioma

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-26
Start Date:
2018-02-01
Completion:
2028-01-01
Conditions
  • Glioma
Interventions
  • DRUG
No Results Yet
NCT02993068 | SUSPENDED | NA
5200 participants

Stand up to Cancer: MAGENTA (Making Genetic Testing Accessible)

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-26
Start Date:
2017-04-18
Completion:
2028-04-18
Conditions
  • BARD1 Gene Mutation
  • BRCA1 Gene Mutation
  • BRCA2 Gene Mutation
  • BRIP1 Gene Mutation
  • Estrogen Receptor Negative
  • HER2/Neu Negative
  • MLH1 Gene Mutation
  • MSH2 Gene Mutation
  • MSH6 Gene Mutation
  • PALB2 Gene Mutation
  • PMS2 Gene Mutation
  • Progesterone Receptor Negative
  • RAD51C Gene Mutation
  • RAD51D Gene Mutation
  • Triple-Negative Breast Carcinoma
Interventions
  • OTHER
No Results Yet
NCT02159495 | ACTIVE_NOT_RECRUITING | PHASE1
31 participants

Genetically Modified T-cell Immunotherapy in Treating Patients With Relapsed/Refractory Acute Myeloid Leukemia and Persistent/Recurrent Blastic Plasmacytoid Dendritic Cell Neoplasm

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-26
Start Date:
2015-12-15
Completion:
2027-07-14
Conditions
  • Adult Acute Myeloid Leukemia in Remission
  • Acute Biphenotypic Leukemia
  • Early Relapse of Acute Myeloid Leukemia
  • Late Relapse of Acute Myeloid Leukemia
  • Recurrent Adult Acute Myeloid Leukemia
  • Secondary Acute Myeloid Leukemia
  • Blastic Plasmacytoid Dendritic Cell Neoplasm
  • Acute Myeloid Leukemia
  • Adult Acute Lymphoblastic Leukemia
  • Interleukin-3 Receptor Subunit Alpha Positive
  • Minimal Residual Disease
  • Refractory Acute Myeloid Leukemia
  • Untreated Adult Acute Myeloid Leukemia
Interventions
  • DRUG
  • BIOLOGICAL
  • OTHER
No Results Yet
NCT01959698 | ACTIVE_NOT_RECRUITING | PHASE1
29 participants

Carfilzomib, Rituximab, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Relapsed or Refractory Stage I-IV Diffuse Large B-cell Lymphoma

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-26
Start Date:
2014-04-17
Completion:
2020-06-01
Conditions
  • CD20 Positive
  • Recurrent Diffuse Large B-Cell Lymphoma
  • Refractory Diffuse Large B-Cell Lymphoma
  • Stage I Diffuse Large B-Cell Lymphoma
  • Stage II Diffuse Large B-Cell Lymphoma
  • Stage III Diffuse Large B-Cell Lymphoma
  • Stage IV Diffuse Large B-Cell Lymphoma
Interventions
  • DRUG
  • OTHER
  • BIOLOGICAL
Results Available
NCT01123018 | COMPLETED
1 participants

Screening for Memory Studies

Study Type:
OBSERVATIONAL
Last Updated:
2026-08-26
Start Date:
2007-06-30
Completion:
2023-12-31
Conditions
  • Memory Loss
  • Memory Deficits
  • Dementia
  • Alzheimer Disease
Interventions
  • BEHAVIORAL
No Results Yet
NCT00792948 | ACTIVE_NOT_RECRUITING | PHASE2
97 participants

Combination Chemotherapy With or Without Donor Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-26
Start Date:
2009-09-01
Completion:
2016-06-01
Conditions
  • Acute Lymphoblastic Leukemia
  • Adult B Acute Lymphoblastic Leukemia
  • Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1
  • Adult L1 Acute Lymphoblastic Leukemia
  • Adult L2 Acute Lymphoblastic Leukemia
  • Adult T Acute Lymphoblastic Leukemia
  • Recurrent Adult Acute Lymphoblastic Leukemia
Interventions
  • PROCEDURE
  • DRUG
  • BIOLOGICAL
  • OTHER
  • RADIATION
Results Available
NCT00575081 | RECRUITING
5000 participants

Physiological Brain Atlas Development

Study Type:
OBSERVATIONAL
Last Updated:
2026-08-26
Start Date:
2006-08-31
Completion:
2027-08-31
Conditions
  • Parkinson's Disease
  • Obsessive Compulsive Disorder
  • Dystonia
  • Essential Tremor
  • Epilepsy
Interventions
  • DEVICE
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page